National Trends in Neoadjuvant Chemotherapy Utilization in Patients with Early-Stage Node-Negative Triple-Negative Breast Cancer: the Impact of the CREATE-X Trial.
BREAST CANCER RESEARCH AND TREATMENT（2024）
Key words
Triple-negative breast cancer,Neoadjuvant chemotherapy,Cancer disparities,Disparities,Healthcare access,Breast cancer,Early-stage breast cancer,CREATEX
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined